Kairos Pharma, Ltd.

KAPA XASE • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

10M

Short interest (May 15)

0.6%

Net Short (Jun 03 ): 0.0%

Borrow Fee

6.22%

↑ 0.6%

Available Shares

↓ 1.8%

Price Chart

Company Overview

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.

Company Info

Exchange: XASE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001962011

Asset Type: CS

Market Data

Market Cap: $10,020,440

Employees: 1

Status: Active

Short Interest

Current Borrow Fee 6.22%

Range: 6.21% - 6.22%

Available Shares 1M

Range: 850K - 1M

Recent Changes

Fee Change: ↑ 1.3%

Available Change: ↓ 2.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime